FATE
Fate Therapeutics Inc.
Company Overview
| Mkt Cap | $110.98M | Price | $1.35 |
| Volume | 1.55M | Change | +4.65% |
| P/E Ratio | -0.6 | Open | $1.40 |
| Revenue | $13.6M | Prev Close | $1.29 |
| Net Income | $-186.3M | 52W Range | $0.66 - $3.50 |
| Div Yield | N/A | Target | $4.45 |
| Overall | 46 | Value | 60 |
| Quality | -- | Technical | 33 |
No chart data available
Stock Overview
Updated DailyFate Therapeutics Inc. (FATE) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.35 with a market capitalization of $110.98 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows FATE with a volume of 1.55 million shares. The stock opened up 8.53% from yesterday's close of $1.29. Current analyst estimates project earnings of $-1.1 per share for this year, with next year targeting $-1.02.
FATE demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including SRPT, BDX, PTCT, RNA, NBIX.
Key investment considerations for FATE include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 229.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.35 | +4.7% | 1.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |